from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1666c/cyp139

LFCtreatmentdescriptionclass of inhibitor

-0.563

Amikacinug/mL Amikacintranslation

0.064

Cap5-10ug/mL Capreomycintranslation

-0.361

Rox10-50 ug/mL Roxithromycintranslation

-0.631

SM2-5 ug/mL Streptomycintranslation

-2.219

Tet5-10 ug/mL Tetracyclinetranslation

0.241

Rif0.2-5ug/mL Rifampicintranscription

0.380

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.116

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.142

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.194

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.477

Clofazimine10-13 ug/mL Clofaziminerespiration

0.416

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.970

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.077

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.138

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.504

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.778

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.525

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.434

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.045

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.113

KCN5-20 ug/mL Potassium cyaniderespiration

0.144

NaN30.2-2 mM Sodium aziderespiration

0.338

Nigericin50 uM Nigericinrespiration

-0.041

TRC10-150 ug/mL Triclosanrespiration

0.085

TRZ10-25 ug/mL Thioridazinerespiration

-2.267

Valinomycin0.5-10 uM Valinomycinrespiration

-0.615

ZnSO42 mM ZnSO4respiration

-1.418

menadione6-10 ug/mL Menadionerespiration

0.096

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.091

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.075

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.098

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.254

NRP_1Non-replicating persistence stage 1dosRassociated

-0.001

Amp0.2mg/mL AmpicillincellWall

0.355

Cephalexin20-100 ug/mL CephalexincellWall

-0.075

Cerulenin0.32-5 ug/mL CerulenincellWall

1.151

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.069

EMB10-20 ug/mL EthambutolcellWall

0.246

Eta12-40 ug/mL EthionamidecellWall

-0.145

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.988

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.508

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.359

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

2.028

BZA0.12 mg/mL BenzamidearomaticAmides

0.365

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.731

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.377

H2O24 mM hydrogen peroxideDNAdamaging

0.115

Levo10 ug/mL LevofloxacinDNAdamaging

0.495

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.477

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.572

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.522

UVUV-irradiationDNAdamaging

-0.945

ARP41-4 ug/mL Antitubercular compound ARP4?

0.318

Antimycin12.5-50 ug/mL Antimycin A?

-0.156

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.192

PA_110-50 ug/mL Antitubercular compound PA-1?

0.166

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.370

PA8240.2-2 ug/mL PA-824?

-1.101

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.112

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.042

Verapamil50 uM Verapamil?

-0.271

mercaptoethanol2 mM 2-Mercaptoethanol?

0.210

methoxatin10-20 ug/mL Methoxatin?